Meeting of the Advisory Committee; Meeting, 19987-19988 [2023-06977]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 64 / Tuesday, April 4, 2023 / Notices
ACTION:
Notice.
The Commission hereby gives
notice of the scheduling of expedited
reviews pursuant to the Tariff Act of
1930 (‘‘the Act’’) to determine whether
revocation of the antidumping duty and
countervailing duty orders on hardwood
plywood from China would be likely to
lead to continuation or recurrence of
material injury within a reasonably
foreseeable time.
DATES: March 6, 2023.
FOR FURTHER INFORMATION CONTACT:
(Stamen Borisson (202) 205–3125),
Office of Investigations, U.S.
International Trade Commission, 500 E
Street SW, Washington, DC 20436.
Hearing-impaired persons can obtain
information on this matter by contacting
the Commission’s TDD terminal on 202–
205–1810. Persons with mobility
impairments who will need special
assistance in gaining access to the
Commission should contact the Office
of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server (https://
www.usitc.gov). The public record for
this proceeding may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov.
SUPPLEMENTARY INFORMATION:
Background.—On March 6, 2023, the
Commission determined that the
domestic interested party group
response to its notice of institution (87
FR 73792, December 1, 2022) of the
subject five-year reviews was adequate
and that the respondent interested party
group response was inadequate. The
Commission did not find any other
circumstances that would warrant
conducting full reviews.1 Accordingly,
the Commission determined that it
would conduct expedited reviews
pursuant to section 751(c)(3) of the
Tariff Act of 1930 (19 U.S.C.
1675(c)(3)).2
For further information concerning
the conduct of these reviews and rules
of general application, consult the
Commission’s Rules of Practice and
Procedure, part 201, subparts A and B
(19 CFR part 201), and part 207,
subparts A, D, E, and F (19 CFR part
207).
Staff report.—A staff report
containing information concerning the
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
1 A record of the Commissioners’ votes, the
Commission’s statement on adequacy, and any
individual Commissioner’s statements will be
available from the Office of the Secretary and at the
Commission’s website.
2 Chairman David S. Johanson and Commissioner
Amy A. Karpel found that the respondent interested
party group response was adequate and voted to
conduct full reviews.
VerDate Sep<11>2014
19:41 Apr 03, 2023
Jkt 259001
subject matter of the reviews has been
placed in the nonpublic record, and will
be made available to persons on the
Administrative Protective Order service
list for these reviews on April 19, 2023.
A public version will be issued
thereafter, pursuant to § 207.62(d)(4) of
the Commission’s rules.
Written submissions.—As provided in
§ 207.62(d) of the Commission’s rules,
interested parties that are parties to the
reviews and that have provided
individually adequate responses to the
notice of institution,3 and any party
other than an interested party to the
reviews may file written comments with
the Secretary on what determination the
Commission should reach in the
reviews. Comments are due on or before
April 27, 2023 and may not contain new
factual information. Any person that is
neither a party to the five-year reviews
nor an interested party may submit a
brief written statement (which shall not
contain any new factual information)
pertinent to the reviews by April 27,
2023. However, should the Department
of Commerce (‘‘Commerce’’) extend the
time limit for its completion of the final
results of its reviews, the deadline for
comments (which may not contain new
factual information) on Commerce’s
final results is three business days after
the issuance of Commerce’s results. If
comments contain business proprietary
information (BPI), they must conform
with the requirements of §§ 201.6,
207.3, and 207.7 of the Commission’s
rules. The Commission’s Handbook on
Filing Procedures, available on the
Commission’s website at https://
www.usitc.gov/documents/handbook_
on_filing_procedures.pdf, elaborates
upon the Commission’s procedures with
respect to filings.
In accordance with §§ 201.16(c) and
207.3 of the rules, each document filed
by a party to the reviews must be served
on all other parties to the reviews (as
identified by either the public or BPI
service list), and a certificate of service
must be timely filed. The Secretary will
not accept a document for filing without
a certificate of service.
3 The Commission has found the domestic
interested party responses submitted on behalf of
the Coalition for Fair Trade in Hardwood Plywood
and its individual members, Columbia Forest
Products, Commonwealth Plywood Co., Ltd.,
Manthei Wood Products, States Industries LLC, and
Timber Products Company, and respondent
interested party responses submitted on behalf of
Canusa Wood Products Limited, Hardwoods
Specialty Products USLP, Holland Southwest
International, Inc., McCorry & Company Limited,
Medallion Forest Products, Northwest Hardwoods,
Inc., Richmond International Forest Products, LLC,
and Taraca Pacific, Inc., to be individually
adequate. Comments from other interested parties
will not be accepted (see 19 CFR 207.62(d)(2)).
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
19987
Determination.—The Commission has
determined these reviews are
extraordinarily complicated and
therefore has determined to exercise its
authority to extend the review period by
up to 90 days pursuant to 19 U.S.C.
1675(c)(5)(B).
Authority: These reviews are being
conducted under authority of title VII of
the Tariff Act of 1930; this notice is
published pursuant to § 207.62 of the
Commission’s rules.
By order of the Commission.
Issued: March 30, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023–06971 Filed 4–3–23; 8:45 am]
BILLING CODE 7020–02–P
JOINT BOARD FOR THE
ENROLLMENT OF ACTUARIES
Meeting of the Advisory Committee;
Meeting
Joint Board for the Enrollment
of Actuaries.
ACTION: Notice of Federal Advisory
Committee meeting.
AGENCY:
The Joint Board for the
Enrollment of Actuaries gives notice of
a closed teleconference meeting of the
Advisory Committee on Actuarial
Examinations.
SUMMARY:
The meeting will be held on
April 21, 2023, from 10:00 a.m. to 5:00
p.m. (EDT).
FOR FURTHER INFORMATION CONTACT:
Elizabeth Van Osten, Designated Federal
Officer, Advisory Committee on
Actuarial Examinations, at (202) 317–
3648 or elizabeth.j.vanosten@irs.gov.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that the Advisory
Committee on Actuarial Examinations
will hold a teleconference meeting on
April 21, 2023, from 10:00 a.m. to 5:00
p.m. (EDT). The meeting will be closed
to the public.
The purpose of the meeting is to
discuss topics and questions that may
be recommended for inclusion on future
Joint Board examinations in actuarial
mathematics, pension law and
methodology referred to in 29 U.S.C.
1242(a)(1)(B).
A determination has been made as
required by section 10(d) of the Federal
Advisory Committee Act, 5 U.S.C. 1009,
that the subject of the meeting falls
within the exception to the open
meeting requirement set forth in 5
U.S.C. 552b(c)(9)(B), and that the public
interest requires that such meeting be
closed to public participation.
DATES:
E:\FR\FM\04APN1.SGM
04APN1
19988
Federal Register / Vol. 88, No. 64 / Tuesday, April 4, 2023 / Notices
Dated: March 30, 2023.
Thomas V. Curtin, Jr.,
Executive Director, Joint Board for the
Enrollment of Actuaries.
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on February 8, 2023, Sharp
Clinical Services, LLC, 2400 Baglyos
Circle, Bethlehem, Pennsylvania 18020–
8024, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
[FR Doc. 2023–06977 Filed 4–3–23; 8:45 am]
BILLING CODE 4830–01–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug
code
Controlled substance
[Docket No. DEA–1160]
Importer of Controlled Substances
Application: Sharp Clinical Services,
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
Gamma Hydroxybutyric Acid
3,4Methylenedioxymethamphetamine.
5-Methoxy-N-Ndimethyltryptamine.
Schedule
2010
7405
I
I
7431
I
AGENCY:
Sharp Clinical Services, LLC
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before May 4, 2023. Such persons
may also file a written request for a
hearing on the application on or before
May 4, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
19:41 Apr 03, 2023
Jkt 259001
The company plans to import the
listed controlled substances for
distribution and clinical trials. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–06948 Filed 4–3–23; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on January 28, 2023,
SpecGX LLC, 3600 North 2nd Street,
Saint Louis, Missouri 63147, applied to
be registered as an importer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Drug Enforcement Administration
[Docket No. DEA–1177]
Importer of Controlled Substances
Application: SpecGX LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
SpecGX, LLC has applied to
be registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplemental Information
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before May 4, 2023. Such persons
may also file a written request for a
hearing on the application on or before
May 4, 2023.
ADDRESSES: The Drug Enforcement
Administration (DEA) requires that all
SUMMARY:
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
Marihuana .....................
Phenylacetone ..............
Coca Leaves ................
Thebaine .......................
Opium, Raw ..................
Poppy Straw Concentrate.
Tapentadol ....................
Drug
code
Schedule
7360
8501
9040
9333
9600
9670
I
II
II
II
II
II
9780
II
The company plans to import the
listed controlled substances for bulk
manufacture into Active Pharmaceutical
Ingredients (API) for distribution to its
customers. In reference to Tapentadol
(9780) and Thebaine (9333), the
company plans to import intermediate
forms of these controlled substances for
further manufacturing prior to
distribution to its customers. In
reference to drug code 7360
(Marihuana), the company plans to
import synthetic cannabinol. No other
activity for this drug is authorized for
this registration. Placement of these
codes onto the company’s registration
does not translate into automatic
approval of subsequent permit
E:\FR\FM\04APN1.SGM
04APN1
]]>Agencies
[Federal Register Volume 88, Number 64 (Tuesday, April 4, 2023)]
[Notices]
[Pages 19987-19988]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-06977]
=======================================================================
-----------------------------------------------------------------------
JOINT BOARD FOR THE ENROLLMENT OF ACTUARIES
Meeting of the Advisory Committee; Meeting
AGENCY: Joint Board for the Enrollment of Actuaries.
ACTION: Notice of Federal Advisory Committee meeting.
-----------------------------------------------------------------------
SUMMARY: The Joint Board for the Enrollment of Actuaries gives notice
of a closed teleconference meeting of the Advisory Committee on
Actuarial Examinations.
DATES: The meeting will be held on April 21, 2023, from 10:00 a.m. to
5:00 p.m. (EDT).
FOR FURTHER INFORMATION CONTACT: Elizabeth Van Osten, Designated
Federal Officer, Advisory Committee on Actuarial Examinations, at (202)
317-3648 or [email protected].
SUPPLEMENTARY INFORMATION: Notice is hereby given that the Advisory
Committee on Actuarial Examinations will hold a teleconference meeting
on April 21, 2023, from 10:00 a.m. to 5:00 p.m. (EDT). The meeting will
be closed to the public.
The purpose of the meeting is to discuss topics and questions that
may be recommended for inclusion on future Joint Board examinations in
actuarial mathematics, pension law and methodology referred to in 29
U.S.C. 1242(a)(1)(B).
A determination has been made as required by section 10(d) of the
Federal Advisory Committee Act, 5 U.S.C. 1009, that the subject of the
meeting falls within the exception to the open meeting requirement set
forth in 5 U.S.C. 552b(c)(9)(B), and that the public interest requires
that such meeting be closed to public participation.
[[Page 19988]]
Dated: March 30, 2023.
Thomas V. Curtin, Jr.,
Executive Director, Joint Board for the Enrollment of Actuaries.
[FR Doc. 2023-06977 Filed 4-3-23; 8:45 am]
BILLING CODE 4830-01-P
